EGFR and non-small cell lung carcinoma: It will be therefore interesting to investigate how GAPDH could contribute with FDG uptake level and tumor stage in building a composite prognostic marker, possibly also correlating it with the status of known NSCLC oncogenic genes (PI3K, EGFR, KRAS, ALK, etc.).